← Open Payments lookup

ANDREA KEANE: Open Payments

NPI 1720414915 · SEYMOUR, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$972 in 62 payments from 12 companies in 2025. Trend: 2023 $920 · 2024 $1,376 · 2025 $972

Food & beverage: $963Education: $9
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.12$179
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)14$172
ABBVIE INC.12$172
Indivior Inc.5$92
Braeburn Inc.4$70
Alkermes, Inc.3$68
Lundbeck LLC2$46
Takeda Pharmaceuticals U.S.A., Inc.3$45
Gilead Sciences, Inc.2$38
Axsome Therapeutics, Inc.2$37

Products named: CAPLYTA, VRAYLAR, SUBLOCADE, REXULTI, ABILIFY MAINTENA, BRIXADI, ARISTADA, ABILIFY ASIMTUFII.

Industry payments across IN — which companies pay providers there.